Meropenem 500mg Pediatric IV Vial from Canada
Pediatric formulation vial with 500mg meropenem for weight-based dosing in children treating sepsis or complicated skin infections. Falls under HTS 3004.20.00.76 as a meropenem-containing antibiotic in measured doses for prophylactic and therapeutic uses in hospital settings. Dosage adjusted for safety in young patients.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include pediatric-specific clinical trial data or approvals in documentation for age-appropriate importing
• Monitor for color change indicators on vials, as degradation affects classification and import viability
• Pair with import bonds for high-value pharmaceuticals to cover potential FDA holds